Ann: Mesoblast Phase 3 Chronic Low Back Pain Results, page-330

If i recall correctly Si got in a bit of bother with major shareholders a couple of years back with CHF results regarding lvad weening. The announcment appeared to focus on the negative.

wondering if this has anything to do with the wording of recent announcements.

Anyway this one was better then i expected.
So from now on the team has some solid data from the last phase 3s regarding time of administration and method of action as i mentioned a few months back. Any further trials will be designed with a much clearer focus.

prove once and for all the method of action
Sort out the manufacturing niggles
present it in crayon to the fda
shove it up they're backside
profit

bit over simplified but there you go.

should eventually lead to some quality entertainment for the long termers at the end of a long road.